Ajinomoto Bio-Pharma

Company Snapshot

Founded: 2018
Entity Type: Private
Region: U.S.
Headquarter: U.S.
Key Geographics: North America, Europe, Asia-Pacific
Corporate Address: 11040 Roselle Street San Diego California 92121 U.S. Tel. +1-(858)-882-0123 www.ajibio-pharma.com

Company Overview

Ajinomoto Bio-Pharma is a subsidiary of Ajinomoto Co. Inc. that offers CDMO services. It provides scalable and high-quality custom oligonucleotides and peptides for cGMP or non-GMP applications. Ajinomoto Bio-Pharma operates through various locations across Belgium, the U.S., Japan and India. It offers its services through innovative platforms for preclinical, pilot and commercial scales.

Ajinomoto Bio-Pharma In Reports

Oligonucleotides: Global Markets

According to BCC Research detailed report on oligonucleotide market includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Clinical and Commercial Products : The company provides comprehensive process development services, cGMP manufacturing, drug product fill/finish services of small molecule, and biologic APIs and intermediates.

Applications/End User Industries

  • Healthcare
  • Pharmaceuticals
  • Life Sciences
AI Sentiment